Skip to main content
Top
Published in: AIDS and Behavior 1/2011

01-01-2011 | Report

Perceived Serosorting of Injection Paraphernalia Sharing Networks among Injection Drug users in Baltimore, MD

Authors: C. Yang, K. Tobin, C. Latkin

Published in: AIDS and Behavior | Issue 1/2011

Login to get access

Abstract

We examined perceived serosorting of injection paraphernalia sharing networks among a sample of 572 injection drug users (IDUs). There was evidence for serosorting of high-risk injection behaviors among HIV-negative IDUs, as 94% of HIV-negative IDUs shared injection paraphernalia exclusively with perceived HIV-negative networks. However, 82% of HIV-positive IDUs shared injection paraphernalia with perceived HIV-negative networks. The findings indicate a potential risk of rapid HIV transmission. Future prevention efforts targeting IDUs should address the limitation of serosorting, and focus on preventing injection paraphernalia sharing regardless of potential sharing networks’ perceived HIV status.
Literature
1.
go back to reference Parsons JT, Schrimshaw EW, Wolitski RJ, Halkitis PN, Purcell DW, Hoff CC, et al. Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS. 2005;19(Suppl 1):S13–25.CrossRefPubMed Parsons JT, Schrimshaw EW, Wolitski RJ, Halkitis PN, Purcell DW, Hoff CC, et al. Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS. 2005;19(Suppl 1):S13–25.CrossRefPubMed
2.
go back to reference Eaton LA, Kalichman SC, Cain DN, Cherry C, Stearns HL, Amaral CM, et al. Serosorting sexual partners and risk for HIV among men who have sex with men. Am J Prev Med. 2007;33(6):479–85.CrossRefPubMed Eaton LA, Kalichman SC, Cain DN, Cherry C, Stearns HL, Amaral CM, et al. Serosorting sexual partners and risk for HIV among men who have sex with men. Am J Prev Med. 2007;33(6):479–85.CrossRefPubMed
3.
go back to reference Jin F, Crawford J, Prestage GP, Zablotska I, Imrie J, Kippax SC, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS. 2009;23(2):243–52.CrossRefPubMed Jin F, Crawford J, Prestage GP, Zablotska I, Imrie J, Kippax SC, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS. 2009;23(2):243–52.CrossRefPubMed
4.
go back to reference Mizuno Y, Purcell DW, Latka MH, Metsch LR, Ding H, Gomez CA, et al. Is sexual serosorting occurring among HIV-positive injection drug users? comparison between those with HIV-positive partners only, HIV-negative partners only, and those with any partners of unknown status. AIDS Behav. 2009;14(1):92–102.CrossRefPubMed Mizuno Y, Purcell DW, Latka MH, Metsch LR, Ding H, Gomez CA, et al. Is sexual serosorting occurring among HIV-positive injection drug users? comparison between those with HIV-positive partners only, HIV-negative partners only, and those with any partners of unknown status. AIDS Behav. 2009;14(1):92–102.CrossRefPubMed
5.
go back to reference Metsch LR, Pereyra M, Purcell DW, Latkin CA, Malow R, Gomez CA, et al. Correlates of lending needles/syringes among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007;46(Suppl 2):S72–9.PubMed Metsch LR, Pereyra M, Purcell DW, Latkin CA, Malow R, Gomez CA, et al. Correlates of lending needles/syringes among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007;46(Suppl 2):S72–9.PubMed
6.
go back to reference Parsons JT, VanOra J, Missildine W, Purcell DW, Gomez CA. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Educ Prev. 2004;16(5):459–75.CrossRefPubMed Parsons JT, VanOra J, Missildine W, Purcell DW, Gomez CA. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Educ Prev. 2004;16(5):459–75.CrossRefPubMed
7.
go back to reference Butler DM, Smith DM. Serosorting can potentially increase HIV transmissions. AIDS. 2007;21(9):1218–20.CrossRefPubMed Butler DM, Smith DM. Serosorting can potentially increase HIV transmissions. AIDS. 2007;21(9):1218–20.CrossRefPubMed
8.
go back to reference Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef
9.
go back to reference Barrera MA. Social support in the adjustment of pregnant adolescents: assessment issues. In: Gottlieb BH, editor. Social networks and social support. Beverly Hills, CA: Sage, 1981: 69–96. Barrera MA. Social support in the adjustment of pregnant adolescents: assessment issues. In: Gottlieb BH, editor. Social networks and social support. Beverly Hills, CA: Sage, 1981: 69–96.
10.
go back to reference Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(3):273–80.PubMed Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(3):273–80.PubMed
11.
go back to reference Orr ST, Celentano DD, Santelli J, Burwell L. Depressive symptoms and risk-factors for HIV acquisition among black-women attending urban health centers in Baltimore. AIDS Educ Prev. 1994;6(3):230–6.PubMed Orr ST, Celentano DD, Santelli J, Burwell L. Depressive symptoms and risk-factors for HIV acquisition among black-women attending urban health centers in Baltimore. AIDS Educ Prev. 1994;6(3):230–6.PubMed
12.
go back to reference Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol. 1994;22(3):415–30.CrossRefPubMed Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol. 1994;22(3):415–30.CrossRefPubMed
Metadata
Title
Perceived Serosorting of Injection Paraphernalia Sharing Networks among Injection Drug users in Baltimore, MD
Authors
C. Yang
K. Tobin
C. Latkin
Publication date
01-01-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9713-0

Other articles of this Issue 1/2011

AIDS and Behavior 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.